Latest Breaking News On - Herman goossens - Page 1 : comparemela.com

Belgium developing new class of antibiotics, but incentives and market support needed

Belgium developing new class of antibiotics, but incentives and market support needed
euractiv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.com Daily Mail and Mail on Sunday newspapers.

Bruxelles capitaleStella kyriakidesAbel garcia pinoAndrea chiarelloKevin outtersonHerman goossensEuropean commissionIndustry allianceEu government affairs at pfizerUniversity of antwerpEu healthInternational federation of pharmaceutical manufacturersInternational federationPharmaceutical manufacturersEmeritus professorProfessor goossens

Intravenous Vitamin C for Patients Hospitalized With COVID-19

Two randomized clinical trials were harmonized to compare the effect of vitamin C vs control on outcomes in hospitalized patients with COVID-19 who were critica

United statesNew delhiSaudi arabiaKrung thep mahanakhonWestern australiaCity ofUnited kingdomNational universitySan franciscoSouth australiaNew zealandNorthern irelandFrance generalWellington hillsNorthern territoryAr riya

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This randomized clinical trial examines the effect of initiation of a renin-angiotensin system inhibitor (ACE inhibitor or an angiotensin receptor blocker) on t

Eteläuomen läiSaudi arabiaSri lankaUniversity of minnesotaUnited statesSan franciscoNew south walesCity ofUnited kingdomKrung thep mahanakhonBritish columbiaFrance generalNew zealandWestern australiaNorthern irelandSouth australia

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial | Critical Care Medicine | JAMA

This secondary analysis of an ongoing adaptive platform trial examines the effect of multiple interventions for critically ill adults with COVID-19 on longer-te

United kingdomSouth australiaFrance generalCity ofBritish columbiaUnited statesWestern australiaSan franciscoNew zealand generalNew zealandEstado de pernambucoNational universityEteläuomen läiSao pauloSri lankaAr riya

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This randomized clinical trial assesses the effect of treatment with an antiplatelet agent vs no antiplatelet therapy on days alive and free of intensive care u

Nordrhein westfalenCity ofUnited kingdomFrance generalBritish columbiaUnited statesBedford parkSouth australiaFlinders universityWestern australiaSan franciscoNew zealand generalNew zealandEstado de pernambucoNational university of singaporeSingapore general